Webinar: Using Biomarkers for COVID-19

Infection with SARS-CoV-2 results in COVID-19. This infection has systemic manifestations, including acute lung injury, cardiac damage, and in rare cases a Kawasaki disease-like illness. With rising cases of COVID-19 nationally, clinicians can benefit from tools to inform decisions regarding triage, advanced imaging, and treatment.

Biomarker testing has emerged as a potentially useful tool to facilitate clinical decision making. It can highlight risks in patients with COVID-19, prognosticating poor outcome, and help determine where patients should be admitted (e.g., medical floor vs. ICU), how they should be imaged, and whether to apply more advanced treatments.

In this P.A.C.E.-accredited Fisher Healthcare webinar presented by Dr. James Louis Januzzi, review of data will focus on use of troponins, natriuretic peptides, and other biomarkers in a clinically focused synthesis of how biomarkers might be used in COVID-19 assessment.

Click here fore more information